Drug intelligence / Profile preview

allogeneic red blood cells

Development stage
Unknown
Lead developer
Rubius Therapeutics
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous Transfusion
01

Overview

Allogeneic red blood cells are human erythrocytes collected from a donor and transfused into a different individual. They are used to treat anemia, acute or chronic blood loss, and other conditions requiring restoration of oxygen-carrying capacity. The mechanism of action is the direct replacement of lost or deficient endogenous erythrocytes, thereby increasing hemoglobin concentration and improving tissue oxygenation. Allogeneic RBCs can be processed into various forms such as suspended (packed) RBCs, leukocyte-reduced RBCs, washed RBCs, or irradiated RBCs to reduce adverse reactions. They are stored refrigerated for up to 42 days with additive solutions (AS-1/AS-3/AS-5), or cryopreserved for longer periods[6][8][10]. Indications include trauma-related hemorrhage, surgery-associated bleeding, severe anemia due to chronic disease or chemotherapy, and certain hematological disorders.

Other names
packed red blood cellsPRBCsdonor red blood cells异体红细胞

Beyond the preview

Go deeper on allogeneic red blood cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic red blood cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call